Sign in
05A Design considerations for phase II neuroclinical trials
Abstract

05A Design considerations for phase II neuroclinical trials

Wayne M Alves, James C Torner and Mark C Wolff
Controlled clinical trials, Vol.15(3), pp.34-35
06/1994
DOI: 10.1016/0197-2456(94)90066-3

View Online

Details

Metrics

5 Record Views